ABCL AbCellera Biologics Inc. - Common Shares
NASDAQ · Life Sciences Tools & Services · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$13.74
· of 52w range
· above low
· to high
$2.7552w low
$15.0252w high
Market Cap (MRQ)
$4.21B
P/E (TTM)
-25.4
EPS (TTM)
$-0.54
Revenue (TTM)
$66M
your badges
52W Range
$3–$15
Analyst Rating
BUY
Price Target
$17
P/E
-25.4
ROE
-17.3%
Net Profit Margin
-248.8%
Your badge strip is empty — pin a metric anywhere on this page.
ABCL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$13.74
Market Cap (MRQ)
$4.21B
P/E (TTM)
-25.4
EPS (TTM)
$-0.54
Revenue (TTM)
$66M
ROE (TTM)
-17.3%
52W Range
$3–$15
ABCL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$75M2019-12-31 → 2025-12-31
EPS$-0.492019-12-31 → 2025-12-31
Free Cash Flow$-174M2022-12-31 → 2025-12-31
Net margin-248.8%2022-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ABCL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -25.45Y avg ≈5.3 | ≈5.3 | · | · | |
| P/S (TTM) | 63.65Y avg ≈23.3 | ≈23.3 | · | · | |
| P/B (MRQ) | 4.75Y avg ≈1.4 | ≈1.4 | · | · | |
| Price / FCF (TTM) | -35.25Y avg ≈-2.6 | ≈-2.6 | · | · | |
| Price / Cash Flow (TTM) | -44.45Y avg ≈-10.8 | ≈-10.8 | · | · | |
| Price / Tangible Book (MRQ) | 4.95Y avg ≈2.3 | ≈2.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ABCL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -340.2%5Y avg ≈-490.0% | ≈-490.0% | · | · | |
| EBITDA Margin | -289.0%5Y avg ≈-490.0% | ≈-490.0% | · | · | |
| Pretax Margin (TTM) | -297.4%5Y avg ≈-335.0% | ≈-335.0% | · | · | |
| Net Profit Margin (TTM) | -248.8%5Y avg ≈-278.0% | ≈-278.0% | · | · | |
| ROA (TTM) | -12.2%5Y avg ≈-5.2% | ≈-5.2% | · | · | |
| ROE (TTM) | -17.3%5Y avg ≈-7.5% | ≈-7.5% | · | · | |
| ROIC | -18.5%5Y avg ≈-12.1% | ≈-12.1% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ABCL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 12.85Y avg ≈9.3 | ≈9.3 | · | · | |
| Quick Ratio | 2.65Y avg ≈2.4 | ≈2.4 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ABCL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 160.6%5Y avg ≈26.9% | ≈26.9% | · | · | |
| Revenue CAGR 3Y | -46.3%5Y avg ≈-49.7% | ≈-49.7% | · | · | |
| Revenue CAGR 5Y | -20.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ABCL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.1 | ≈0.1 | · | · | |
| Receivables Turnover | 2.1 | · | · | · | |
| Revenue / Employee | ≈$133.7K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
17.4%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 6, 2026 | $-0.18 | $-0.15 | -23.5% |
| March 31, 2026 | May 10, 2026 | $-0.14 | $-0.20 | 29.9% |
| Dec. 31, 2025 | $-0.03 | $-0.18 | 83.1% | |
| Sept. 30, 2025 | $-0.19 | $-0.17 | -10.4% | |
| June 30, 2025 | $-0.12 | $-0.17 | 29.1% | |
| March 31, 2025 | $-0.15 | $-0.14 | -3.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $75M | $29M | $38M | $485M | $375M | $233M | $12M | |
| R&D Expense | $187M | $167M | $176M | $108M | $62M | $29M | $10M | |
| SG&A Expense | $83M | $85M | $75M | $55M | $42M | $12M | $3M | |
| Operating Expenses | $292M | $344M | $275M | $269M | $171M | $77M | $16M | |
| Operating Income | $-217M | $-315M | $-237M | $217M | $204M | $156M | $-4M | |
| Interest Income | $28M | $38M | $42M | $16M | $3M | $293.0K | $155.0K | |
| Other Non-op | $-3M | $62M | $7M | $-4M | $-6M | $-7M | $-209.0K | |
| Pretax Income | $-178M | $-200M | $-174M | $239M | $219M | $158M | $-2M | |
| Income Tax | $-31M | $-38M | $-28M | $81M | $66M | $39M | · | |
| Net Income | $-146M | $-163M | $-146M | $159M | $153M | $119M | $-2M | |
| EPS (Basic) | $-0.49 | $-0.55 | $-0.51 | $0.56 | $0.56 | $0.53 | $-0.01 | |
| EPS (Diluted) | $-0.49 | $-0.55 | $-0.51 | $0.50 | $0.48 | $0.45 | $-0.01 | |
| Shares (Basic) | 298,707,082 | 294,327,532 | 289,166,486 | 285,056,606 | 275,763,745 | 159,195,023 | 151,327,560 | |
| Shares (Diluted) | 298,707,082 | 294,327,532 | 289,166,486 | 314,827,255 | 318,294,236 | 263,129,765 | 151,327,560 | |
| EBITDA | $-217M | $-315M | $-237M | $217M | · | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $129M | $156M | $133M | $387M | $476M | $594M | · | |
| Receivables | $39M | $32M | $0 | · | · | $903.0K | · | |
| Inventory | $6M | $0 | · | · | · | · | · | |
| Prepaid Expense | · | · | · | · | · | $4M | · | |
| Other Current Assets | $111M | $67M | $56M | $75M | $21M | $6M | · | |
| Current Assets | $728M | $751M | $872M | $1.03B | $930M | $813M | · | |
| PP&E (Net) | · | · | · | $217M | $112M | $18M | · | |
| PP&E (Gross) | · | · | · | $236M | $121M | $24M | · | |
| Accum. Depreciation | · | · | · | $18M | $10M | $6M | · | |
| Goodwill | $48M | $48M | $48M | $48M | $48M | $32M | · | |
| Intangibles | $38M | $42M | $120M | $132M | $148M | $115M | $0 | |
| Other Non-current Assets | $52M | $97M | $94M | $46M | $31M | $8M | · | |
| Total Assets | $1.36B | $1.36B | $1.49B | $1.54B | $1.32B | $1.01B | · | |
| Accounts Payable | $25M | $34M | $29M | $15M | $15M | $7M | · | |
| Accrued Liabilities | · | · | · | $0 | $0 | · | · | |
| Current Liabilities | $64M | $77M | $119M | $118M | $121M | $103M | · | |
| Capital Leases | $137M | $61M | $71M | $77M | $36M | $4M | · | |
| Deferred Tax | $9M | $10M | $31M | $33M | $37M | $26M | · | |
| Other Non-current Liabilities | $10M | $7M | $6M | $3M | $2M | $7M | · | |
| Total Liabilities | $390M | $304M | $336M | $308M | $293M | $175M | · | |
| Common Stock | $802M | $777M | $753M | $734M | $722M | $710M | · | |
| Retained Earnings | $-29M | $117M | $280M | $426M | $268M | $114M | · | |
| AOCI | $-4M | $-4M | $-2M | $-1M | $280.0K | · | · | |
| Stockholders' Equity | $967M | $1.06B | $1.15B | $1.23B | $1.03B | $831M | $10M | |
| Liabilities + Equity | $1.36B | $1.36B | $1.49B | $1.54B | $1.32B | $1.01B | · | |
| Shares Outstanding | 300,600,710 | 295,757,002 | 290,824,970 | 286,851,595 | 283,257,104 | 269,497,768 | · |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $24M | $28M | $14M | $5M | $2M | |
| Stock-based Comp | $56M | $68M | $64M | $49M | $31M | $8M | $890.0K | |
| Deferred Tax | · | · | $2M | $-2M | $-2M | $2M | · | |
| Amort. of Intangibles | $4M | $14M | $12M | $10M | $10M | $2M | $0 | |
| Operating Cash Flow | $-131M | $-109M | $-44M | $277M | $245M | $23M | $3M | |
| CapEx | $43M | $78M | $77M | $71M | $58M | $10M | $4M | |
| Investing Cash Flow | $88M | $121M | $-221M | $-353M | $-332M | $-120M | $-6M | |
| Debt Issued | · | · | · | · | $872.0K | $15M | $193.0K | |
| Stock Issued | · | · | · | · | · | $523M | · | |
| Financing Cash Flow | $14M | $13M | $10M | $-2M | $-4M | $684M | $195.0K | |
| Net Change in Cash | $-28M | $23M | $-254M | $-86M | $-93M | $587M | $-3M | |
| Free Cash Flow | $-174M | $-187M | $-121M | $207M | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -289.0% | -1091.7% | -623.8% | 44.6% | · | · | · | |
| Net Margin | -194.9% | -564.8% | -385.0% | 32.7% | · | · | · | |
| Pretax Margin | -236.4% | -695.0% | -457.7% | 49.3% | · | · | · | |
| EBITDA Margin | -289.0% | -1091.7% | -623.8% | 44.6% | · | · | · | |
| ROA | -10.8% | -11.4% | -9.7% | 11.1% | · | · | · | |
| ROE | -14.8% | -15.3% | -12.5% | 12.8% | · | · | · | |
| ROIC | -18.5% | -24.2% | -17.3% | 11.6% | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.3 | 9.8 | 7.3 | 8.7 | · | · | · | |
| Quick Ratio | 2.6 | 2.5 | 1.1 | 3.3 | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.3 | · | · | · | |
| Receivables Turnover | 2.1 | 1.8 | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.22 | $3.57 | $3.96 | $4.30 | · | · | · | |
| Revenue / Share | $0.25 | $0.10 | $0.13 | $1.54 | · | · | · | |
| Cash Flow / Share | $-0.44 | $-0.37 | $-0.15 | $0.88 | · | · | · | |
| Cash / Share | $0.43 | $0.53 | $0.46 | $1.35 | · | · | · | |
| EPS (TTM) | $-0.49 | $-0.55 | $-0.51 | $0.50 | $0.48 | $0.45 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 160.6% | -24.2% | -92.2% | 29.4% | 60.9% | · | · | |
| Revenue CAGR 3Y | -46.3% | -57.5% | -45.4% | · | · | · | · | |
| Revenue CAGR 5Y | -20.3% | · | · | · | · | · | · | |
| EPS YoY | · | · | · | 4.2% | 6.7% | · | · | |
| Net Income YoY | · | · | · | 3.3% | 29.0% | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75M | $29M | $38M | $485M | $375M | $233M | · | |
| Net Income TTM | $-146M | $-163M | $-146M | $159M | $153M | $119M | · | |
| Market Cap | $1.03B | $867M | $1.66B | $2.91B | · | · | · | |
| P/E | -7.0 | -5.3 | -11.2 | 20.3 | 29.8 | 89.4 | · | |
| P/S | 13.7 | 30.1 | 43.7 | 6.0 | · | · | · | |
| P/B | 1.1 | 0.8 | 1.4 | 2.4 | · | · | · | |
| P / Tangible Book | 1.2 | 0.9 | 1.7 | 2.8 | 4.9 | · | · | |
| P / Cash Flow | -7.8 | -8.0 | -37.8 | 10.5 | · | · | · | |
| P / FCF | -5.9 | -4.6 | -13.7 | 14.1 | · | · | · | |
| Earnings Yield | -14.3% | -18.8% | -8.9% | 4.9% | 3.4% | 1.1% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $8M | $45M | $9M | $17M | $4M | $5M | $7M | $7M | $10M | $9M | $7M | $10M | $12M | $22M | $101M | |
| R&D Expense | $46M | $47M | $50M | $55M | $39M | $42M | $46M | $41M | $41M | $39M | $49M | $38M | $36M | $53M | $28M | $27M | |
| SG&A Expense | $14M | $12M | $26M | $22M | $22M | $19M | $29M | $19M | $20M | $17M | $30M | $14M | $16M | $15M | $13M | $14M | |
| Operating Expenses | $67M | $66M | $73M | $85M | $67M | $67M | $78M | $100M | $101M | $65M | $75M | $61M | $61M | $77M | $59M | $64M | |
| Operating Income | $-63M | $-58M | $-29M | $-76M | $-50M | $-63M | $-73M | $-94M | $-93M | $-55M | $-66M | $-55M | $-51M | $-65M | $-38M | $38M | |
| Interest Income | · | $4M | $6M | $7M | $8M | $6M | $9M | $10M | $10M | $10M | $11M | $11M | $11M | $10M | $8M | $6M | |
| Other Non-op | $4M | $8M | $-156.0K | $-2M | $13M | $10M | $14M | $18M | $32M | $-2M | $3M | $2M | $-2M | $4M | $-4M | $1M | |
| Pretax Income | $-59M | $-50M | $-19M | $-69M | $-36M | $-53M | $-47M | $-63M | $-48M | $-43M | $-49M | $-39M | $-38M | $-48M | $-31M | $47M | |
| Income Tax | $-4M | $-6M | $-11M | $-12M | $-2M | $-7M | $-13M | $-12M | $-11M | $-2M | $-1M | $-11M | $-7M | $-8M | $-2M | $20M | |
| Net Income | $-55M | $-43M | $-9M | $-57M | $-35M | $-46M | $-34M | $-51M | $-37M | $-41M | $-47M | $-29M | $-31M | $-40M | $-30M | $27M | |
| EPS (Basic) | $-0.18 | $-0.14 | $-0.03 | $-0.19 | $-0.12 | $-0.15 | $-0.11 | $-0.17 | $-0.13 | $-0.14 | $-0.16 | $-0.10 | $-0.11 | $-0.14 | $-0.10 | $0.09 | |
| EPS (Diluted) | $-0.18 | $-0.14 | $-0.03 | $-0.19 | $-0.12 | $-0.15 | $-0.11 | $-0.17 | $-0.13 | $-0.14 | $-0.16 | $-0.10 | $-0.11 | $-0.14 | $-0.10 | $0.08 | |
| Shares (Basic) | 305,557,294 | 303,074,605 | · | 298,875,174 | 298,508,601 | 297,692,663 | · | 294,851,945 | 294,217,013 | 292,723,901 | · | 289,496,841 | 288,905,587 | 287,767,136 | · | 285,322,719 | |
| Shares (Diluted) | 305,557,294 | 303,074,605 | · | 298,875,174 | 298,508,601 | 297,692,663 | · | 294,851,945 | 294,217,013 | 292,723,901 | · | 289,496,841 | 288,905,587 | 287,767,136 | · | 315,818,163 | |
| EBITDA | $-56M | $-51M | · | $-76M | $-50M | $-63M | · | $-94M | $-93M | $-55M | · | $-55M | $-51M | $-65M | · | $38M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $120M | $77M | $129M | $83M | $92M | $159M | $156M | $127M | $148M | $124M | · | $172M | $180M | $193M | · | $372M | |
| Receivables | $38M | $39M | $39M | $71M | $70M | $64M | $32M | · | · | · | · | · | · | · | · | · | |
| Inventory | $8M | $8M | $6M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $96M | $98M | $111M | $133M | $117M | $95M | $67M | $43M | $40M | $57M | · | $71M | $64M | $99M | · | $46M | |
| Current Assets | $679M | $665M | $728M | $695M | $742M | $765M | $751M | $743M | $772M | $814M | · | $920M | $931M | $941M | · | $1.05B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $277M | $260M | $233M | · | $201M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $304M | $284M | $255M | · | $216M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $27M | $24M | $21M | · | $16M | |
| Goodwill | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | · | $48M | $48M | $48M | · | $48M | |
| Intangibles | $37M | $37M | $38M | $39M | $40M | $41M | $42M | $53M | $86M | $119M | · | $124M | $127M | $129M | · | $143M | |
| Other Non-current Assets | $62M | $69M | $52M | $53M | $57M | $62M | $97M | $134M | $113M | $105M | · | $81M | $113M | $90M | · | $49M | |
| Total Assets | $1.31B | $1.31B | $1.36B | $1.36B | $1.40B | $1.34B | $1.36B | $1.39B | $1.41B | $1.46B | · | $1.51B | $1.54B | $1.50B | · | $1.55B | |
| Accounts Payable | $12M | $21M | $25M | $32M | $32M | $33M | $34M | $35M | $27M | $27M | · | $17M | $21M | $18M | · | $9M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $53M | $47M | $64M | $69M | $67M | $75M | $77M | $80M | $70M | $105M | · | $110M | $119M | $90M | · | $106M | |
| Capital Leases | $130M | $134M | $137M | $137M | $137M | $63M | $61M | $66M | $66M | $68M | · | $75M | $78M | $77M | · | $72M | |
| Deferred Tax | · | · | $9M | $10M | $10M | $10M | $10M | $13M | $22M | $30M | · | $33M | $33M | $33M | · | $34M | |
| Other Non-current Liabilities | $10M | $11M | $5M | $1M | $2M | $2M | $7M | $2M | $6M | $6M | · | $5M | $2M | $3M | · | $3M | |
| Total Liabilities | $412M | $369M | $390M | $392M | $395M | $321M | $304M | $315M | $302M | $333M | · | $329M | $342M | $289M | · | $302M | |
| Common Stock | $821M | $817M | $802M | $794M | $792M | $790M | $777M | $773M | $770M | $765M | · | $748M | $745M | $743M | · | $730M | |
| Retained Earnings | $-128M | $-73M | $-29M | $-21M | $37M | $71M | $117M | $151M | $202M | $239M | · | $327M | $356M | $386M | · | $456M | |
| AOCI | $-3M | $-2M | $-4M | $-3M | $-3M | $-7M | $-4M | $-1M | $-2M | $-2M | · | $-1M | $-2M | $-2M | · | $-717.0K | |
| Stockholders' Equity | $896M | $938M | $967M | $964M | $1.01B | $1.02B | $1.06B | $1.08B | $1.11B | $1.13B | $1.15B | $1.18B | $1.19B | $1.21B | $1.23B | $1.25B | |
| Liabilities + Equity | $1.31B | $1.31B | $1.36B | $1.36B | $1.40B | $1.34B | $1.36B | $1.39B | $1.41B | $1.46B | · | $1.51B | $1.54B | $1.50B | · | $1.55B | |
| Shares Outstanding | 306,469,632 | 303,945,581 | 300,600,710 | 299,011,566 | 295,757,002 | 295,757,002 | 295,757,002 | 290,824,970 | 290,824,970 | 290,824,970 | · | 286,851,595 | 286,851,595 | 286,851,595 | · | 285,761,492 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $7M | · | $5M | $5M | $5M | · | $37M | $37M | $5M | · | $6M | $6M | $6M | · | $5M | |
| Stock-based Comp | $12M | $12M | $13M | $14M | $14M | $15M | $15M | $17M | $18M | $17M | $16M | $16M | $16M | $15M | $13M | $12M | |
| Amort. of Intangibles | $931.0K | $920.0K | $909.0K | $940.0K | $929.0K | $922.0K | $-54M | $33M | $33M | $2M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-cash | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $26M | $-34M | $-35M | $-53M | $-32M | $-12M | $-8M | $-29M | $-30M | $-42M | $-20M | $-106.0K | $20M | $-44M | $31M | $-127M | |
| CapEx | $2M | $4M | $10M | $9M | $13M | $11M | $16M | $19M | $20M | $24M | $14M | $20M | $27M | $15M | $12M | $13M | |
| Investing Cash Flow | $11M | $-25M | $75M | $36M | $-32M | $8M | $36M | $4M | $52M | $30M | $-24M | $-13M | $-34M | $-150M | $-17M | $-282M | |
| Debt Issued | · | · | · | · | · | · | · | $3M | $2M | $2M | · | $7M | $0 | $0 | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $6M | $7M | $4M | $7M | $-3M | $6M | $4M | $3M | $3M | $3M | $4M | $7M | $419.0K | $-458.0K | $349.0K | $-19.0K | |
| Net Change in Cash | $43M | $-51M | $45M | $-9M | $-67M | $3M | $30M | $-22M | $25M | $-10M | $-39M | $-7M | $-13M | $-194M | $15M | $-417M | |
| Free Cash Flow | · | $-37M | · | · | · | $-22M | · | · | · | $-66M | · | · | · | $-59M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1550.0% | -691.8% | · | -851.8% | -290.2% | -1479.6% | · | -1439.4% | -1276.2% | -551.5% | · | -831.8% | -511.0% | -532.1% | · | 37.2% | |
| Net Margin | -1368.6% | -519.1% | · | -637.8% | -203.3% | -1077.2% | · | -785.4% | -504.3% | -408.0% | · | -433.5% | -303.6% | -329.0% | · | 26.3% | |
| Pretax Margin | -1455.9% | -595.8% | · | -767.9% | -212.7% | -1251.1% | · | -962.5% | -658.0% | -429.5% | · | -595.2% | -377.9% | -394.9% | · | 46.0% | |
| EBITDA Margin | -1377.5% | -609.5% | · | -851.8% | -290.2% | -1479.6% | · | -1439.4% | -1276.2% | -551.5% | · | -831.8% | -511.0% | -532.1% | · | 37.2% | |
| ROA | -4.1% | -3.3% | · | -4.2% | -2.5% | -3.2% | · | -3.5% | -2.5% | -2.7% | · | -1.9% | -1.9% | -2.6% | · | 1.9% | |
| ROE | -5.8% | -4.4% | · | -5.6% | -3.3% | -4.2% | · | -4.5% | -3.2% | -3.5% | · | -2.4% | -2.5% | -3.3% | · | 2.4% | |
| ROIC | -6.6% | -5.3% | · | -6.6% | -4.7% | -5.3% | · | -7.1% | -6.5% | -4.6% | · | -3.4% | -3.5% | -4.5% | · | 1.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.8 | 14.1 | · | 10.1 | 11.1 | 10.1 | · | 9.3 | 11.0 | 7.8 | · | 8.3 | 7.8 | 10.5 | · | 9.9 | |
| Quick Ratio | 3.0 | 2.5 | · | 2.2 | 2.4 | 3.0 | · | 1.6 | 2.1 | 1.2 | · | 1.6 | 1.5 | 2.2 | · | 3.5 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 0.1 | 0.2 | · | 0.3 | 0.5 | 0.1 | · | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.92 | $3.09 | · | $3.22 | $3.41 | $3.46 | · | $3.71 | $3.82 | $3.89 | · | $4.12 | $4.17 | $4.21 | · | $4.37 | |
| Revenue / Share | $0.01 | $0.03 | · | $0.03 | $0.06 | $0.01 | · | $0.02 | $0.02 | $0.03 | · | $0.02 | $0.03 | $0.04 | · | $0.32 | |
| Cash Flow / Share | · | $-0.11 | · | · | · | $-0.04 | · | · | · | $-0.14 | · | · | · | $-0.15 | · | · | |
| Cash / Share | $0.39 | $0.25 | · | $0.28 | $0.31 | $0.54 | · | $0.44 | $0.51 | $0.42 | · | $0.60 | $0.63 | $0.67 | · | $1.30 | |
| EPS (TTM) | $-0.54 | $-0.48 | · | $-0.57 | $-0.55 | $-0.56 | · | $-0.60 | $-0.53 | $-0.51 | · | $-0.45 | $-0.27 | $-0.18 | · | $0.80 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $66M | $79M | · | $35M | $33M | $23M | · | $33M | $33M | $36M | · | $50M | $145M | $181M | · | $603M | |
| Net Income TTM | $-165M | $-144M | · | $-172M | $-166M | $-168M | · | $-176M | $-153M | $-147M | · | $-129M | $-74M | $-50M | · | $248M | |
| Market Cap | $2.41B | $1.06B | · | $1.50B | $1.01B | $660M | · | $756M | $861M | $1.32B | · | $1.32B | $1.85B | $2.16B | · | $2.83B | |
| P/E | -14.5 | -7.3 | · | -8.8 | -6.2 | -4.0 | · | -4.3 | -5.6 | -8.9 | · | -10.2 | -23.9 | -41.9 | · | 12.4 | |
| P/S | 36.4 | 13.4 | · | 42.6 | 30.9 | 28.5 | · | 22.9 | 26.0 | 36.8 | · | 26.2 | 12.8 | 11.9 | · | 4.7 | |
| P/B | 2.7 | 1.1 | · | 1.6 | 1.0 | 0.6 | · | 0.7 | 0.8 | 1.2 | · | 1.1 | 1.6 | 1.8 | · | 2.3 | |
| P / Tangible Book | 3.0 | 1.2 | · | 1.7 | 1.1 | 0.7 | · | 0.8 | 0.9 | 1.4 | · | 1.3 | 1.8 | 2.1 | · | 2.7 | |
| P / Cash Flow | · | -31.6 | · | · | · | -57.1 | · | · | · | -31.6 | · | · | · | -49.1 | · | · | |
| Earnings Yield | -6.9% | -13.8% | · | -11.3% | -16.0% | -25.1% | · | -23.1% | -17.9% | -11.3% | · | -9.8% | -4.2% | -2.4% | · | 8.1% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $75M | $29M | $38M | $485M | $375M |
| Operating Margin % | -289.0% | -1091.7% | -623.8% | 44.6% | · |
| Net Income | $-146M | $-163M | $-146M | $159M | $153M |
| Diluted EPS | $-0.49 | $-0.55 | $-0.51 | $0.50 | $0.48 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 11.3 | 9.8 | 7.3 | 8.7 | · |
| Quick Ratio | 2.6 | 2.5 | 1.1 | 3.3 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-174M | $-187M | $-121M | $207M | · |
Institutional owners (13F) 165 filers · $946.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
165
Value held
$946.5M
New positions
44
Exited positions
28
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 44 (+21 vs prior Q) | 28 (+5 vs prior Q) | 41 (-16 vs prior Q) | 54 (+14 vs prior Q) | -11.3M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $259,145,283 | 33,012,138 | 27.38% | Shares |
| Capital World Investors | $106,668,540 | 13,588,349 | 11.27% | Shares |
| TWO SIGMA INVESTMENTS, LP | $81,933,833 | 10,437,431 | 8.66% | Shares |
| TD Waterhouse Canada Inc. | $72,623,873 | 9,568,149 | 7.67% | Shares |
| BANK OF AMERICA CORP /DE/ | $48,211,081 | 6,141,539 | 5.09% | Shares |
| ArrowMark Colorado Holdings LLC | $32,224,996 | 4,105,095 | 3.40% | Shares |
| BlackRock, Inc. | $29,871,676 | 3,805,309 | 3.16% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $26,438,411 | 7,575,476 | 2.79% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22,655,100 | 2,886,000 | 2.39% | Call option |
| Driehaus Capital Management LLC | $22,488,123 | 2,864,729 | 2.38% | Shares |
| TWO SIGMA ADVISERS, LP | $16,682,760 | 4,878,000 | 1.76% | Shares |
| TUDOR INVESTMENT CORP ET AL | $16,196,049 | 2,063,191 | 1.71% | Shares |
| MARSHALL WACE, LLP | $14,932,200 | 1,902,191 | 1.58% | Shares |
| UBS Group AG | $14,684,469 | 1,870,633 | 1.55% | Shares |
| MORGAN STANLEY | $13,101,760 | 1,669,014 | 1.38% | Shares |
| CITADEL ADVISORS LLC | $12,454,119 | 1,586,512 | 1.32% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $9,679,124 | 1,233,014 | 1.02% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $8,163,427 | 1,039,927 | 0.86% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $7,778,793 | 990,929 | 0.82% | Shares |
| Counterpoint Mutual Funds LLC | $7,627,398 | 971,643 | 0.81% | Shares |
| CITADEL ADVISORS LLC | $6,203,855 | 790,300 | 0.66% | Call option |
| STATE STREET CORP | $5,741,192 | 731,362 | 0.61% | Shares |
| DNB Asset Management AS | $5,318,210 | 677,479 | 0.56% | Shares |
| Guardian Partners Inc. | $4,678,584 | 595,998 | 0.49% | Shares |
| Daiwa Securities Group Inc. | $4,407,775 | 561,500 | 0.47% | Put option |
| Intellectus Partners, LLC | $4,329,925 | 551,583 | 0.46% | Shares |
| Alyeska Investment Group, L.P. | $4,133,629 | 526,577 | 0.44% | Shares |
| MILLENNIUM MANAGEMENT LLC | $4,070,782 | 518,571 | 0.43% | Shares |
| BANK OF MONTREAL /CAN/ | $3,789,972 | 482,799 | 0.40% | Shares |
| Sculptor Capital LP | $3,563,900 | 454,000 | 0.38% | Shares |
| Sculptor Capital LP | $3,563,900 | 454,000 | 0.38% | Put option |
| OSAIC HOLDINGS, INC. | $3,201,970 | 407,898 | 0.34% | Shares |
| ROYAL BANK OF CANADA | $3,167,000 | 403,324 | 0.33% | Shares |
| BANK OF MONTREAL /CAN/ | $3,164,335 | 403,100 | 0.33% | Put option |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $3,140,000 | 400,000 | 0.33% | Shares |
| CITADEL ADVISORS LLC | $2,922,555 | 372,300 | 0.31% | Put option |
| SOFTBANK GROUP CORP. | $2,709,514 | 345,161 | 0.29% | Shares |
| Decker Retirement Planning Inc. | $2,638,479 | 336,112 | 0.28% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $2,478,409 | 315,721 | 0.26% | Shares |
| Daiwa Securities Group Inc. | $2,445,275 | 311,500 | 0.26% | Shares |
| NORTHERN TRUST CORP | $2,344,128 | 298,615 | 0.25% | Shares |
| Daiwa Securities Group Inc. | $1,962,500 | 250,000 | 0.21% | Call option |
| Headlands Technologies LLC | $1,933,078 | 246,252 | 0.20% | Shares |
| ExodusPoint Capital Management, LP | $1,867,923 | 237,952 | 0.20% | Shares |
| GOLDMAN SACHS GROUP INC | $1,845,747 | 235,127 | 0.20% | Shares |
| Man Group plc | $1,797,485 | 228,979 | 0.19% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,694,030 | 215,800 | 0.18% | Put option |
| CITIZENS FINANCIAL GROUP INC/RI | $1,663,337 | 211,890 | 0.18% | Shares |
| UBS Group AG | $1,570,000 | 200,000 | 0.17% | Put option |
| GROUP ONE TRADING LLC | $1,560,525 | 198,793 | 0.16% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Peter Thiel, ABE Investments LLC, The Founders Fund VII Principals Fund, LP, The Founders Fund VII, LP, The Founders Fund VII Entrepreneurs Fund, LP, The Founders Fund VII Management, LLC, The Founders Fund Growth, LP, The Founders Fund Growth Principals Fund, LP, The Founders Fund Growth Management, LLC ×2 filings | April 24, 2023 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 14 insiders · 5 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Carl L. G. Hansen | Chief Executive Officer | Jan. 1, 2026 A | 898,000 | 0 | 0 | $0 |
| Andrew Booth | Chief Financial Officer | Aug. 14, 2026 P | 482,800 | 2 | 0 | $529,596 |
| Tryn Stimart | Chief Legal Officer | Jan. 1, 2026 A | 250 | 0 | 0 | $0 |
| Veronique Lecault | Chief Technology Officer | Jan. 1, 2026 A | 2,123,456 | 0 | 0 | $0 |
| Ester Falconer | Chief Technology Officer | Sept. 1, 2021 M | 875,000 | 0 | 0 | $0 |
| Michael R Hayden | Director | Aug. 24, 2026 P | 1,373,397 | 2 | 0 | $1,051,475 |
| John S. Montalbano | Director | Aug. 18, 2026 P | 251,000 | 3 | 0 | $384,200 |
| Victor Sandor | Director | July 1, 2026 A | · | 0 | 0 | $0 |
| Lynn Seely | Director | July 1, 2026 A | · | 0 | 0 | $0 |
| Stephen Quake | Director | June 11, 2026 A | · | 0 | 0 | $0 |
| Andrew Lo | Director | June 12, 2025 A | 86,938 | 0 | 0 | $0 |
| John Hamer | Director | Sept. 1, 2021 S | 128,862 | 0 | 0 | $0 |
| Peter Thiel | Director | Dec. 15, 2020 C | 24,660 | 0 | 0 | $0 |
| Thermopylae Holdings Ltd. | 10% owner | Feb. 27, 2026 P | 56,134,097 | 2 | 0 | $711,004 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 5 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IDNA · iShares Trust | 2.38% | 582,256 SH | Sept. 11, 2026 | Daily |
| BBC · ETFis Series Trust I | 0.73% | 59,315 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.31% | 22,926 SH | Oct. 1, 2026 | Daily |
| IBB · iShares Trust | 0.18% | 1,792,165 SH | Sept. 11, 2026 | Daily |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.12% | 29,775 SH | Oct. 1, 2026 | Daily |
ABCL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 15 analysts
BUY
Median target
$15.00
+9.2%
3 20.0%
Strong Buy
11 73.3%
Buy
1 6.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
10 analysts · 2026-09-30Mean target $16.70 +21.5%
Now
Current price $13.74
Low$9.00
Mean$16.70
High$30.00
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026